Cargando…

Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium

BACKGROUND: Exacerbations associated with chronic lung infection with Pseudomonas aeruginosa are a major contributor to morbidity, mortality and premature death in cystic fibrosis. Such exacerbations are treated with antibiotics, which generally lead to an improvement in lung function and reduced sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collie, David, Glendinning, Laura, Govan, John, Wright, Steven, Thornton, Elisabeth, Tennant, Peter, Doherty, Catherine, McLachlan, Gerry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636361/ https://www.ncbi.nlm.nih.gov/pubmed/26544950 http://dx.doi.org/10.1371/journal.pone.0142097

Ejemplares similares

A Lung Segmental Model of Chronic Pseudomonas Infection in Sheep
por: Collie, David, et al.
Publicado: (2013)

Variability of the Sheep Lung Microbiota
por: Glendinning, Laura, et al.
Publicado: (2016)

Microbiota in Exhaled Breath Condensate and the Lung
por: Glendinning, Laura, et al.
Publicado: (2017)

Comparing microbiotas in the upper aerodigestive and lower respiratory tracts of lambs
por: Glendinning, Laura, et al.
Publicado: (2017)

Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence
por: de la Rosa-Carrillo, David, et al.
Publicado: (2022)

Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate
por: Chatterjee, Samrat, et al.
Publicado: (2016)

Age-related differences in the respiratory microbiota of chickens
por: Glendinning, Laura, et al.
Publicado: (2017)

Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection
por: Greenwood, James, et al.
Publicado: (2017)

Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections
por: Sadyrbaeva-Dolgova, Svetlana, et al.
Publicado: (2022)

Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis
por: Uttley, Lesley, et al.
Publicado: (2013)

A Novel Validated Injectable Colistimethate Sodium Analysis Combining Advanced Chemometrics and Design of Experiments
por: Dagla, Ioanna, et al.
Publicado: (2021)

Reversible Hypokalemia and Bartter-Like Syndrome during Prolonged Systemic Therapy with Colistimethate Sodium in an Adult Patient
por: Kamal Eldin, Tarek, et al.
Publicado: (2017)

Adverse Events and Drug Resistance in Critically Ill Patients Treated with Colistimethate Sodium: A Review of the Literature
por: Ahumada Topete, Victor Hugo, et al.
Publicado: (2023)

Interaction of Bacterial Phenazines with Colistimethate in Bronchial Epithelial Cells
por: Mossine, Valeri V., et al.
Publicado: (2018)

Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy
por: Koerner-Rettberg, Cordula, et al.
Publicado: (2014)

Neutrophil Gelatinase-associated Lipocalin as a Predictor of Acute Kidney Injury in Patients during Treatment with Colistimethate Sodium
por: Park, So Yeon, et al.
Publicado: (2018)

Modulation of epithelial sodium channel (ENaC) expression in mouse lung infected with Pseudomonas aeruginosa
por: Dagenais, André, et al.
Publicado: (2005)

Microevolution of Pseudomonas aeruginosa in cystic fibrosis lungs
por: Cramer, Nina, et al.
Publicado: (2014)

Lung and Gut Microbiota Changes Associated with Pseudomonas aeruginosa Infection in Mouse Models of Cystic Fibrosis
por: Bacci, Giovanni, et al.
Publicado: (2021)

Gene Expression Changes Associated with the Airway Wall Response to Injury
por: Yahaya, Badrul, et al.
Publicado: (2013)

Effects of sodium houttuyfonate on transcriptome of Pseudomonas aeruginosa
por: Zhao, Yeye, et al.
Publicado: (2019)

Sodium Citrate Alleviates Virulence in Pseudomonas aeruginosa
por: Khayat, Maan T., et al.
Publicado: (2022)

Nebulisation of synthetic lamellar lipids mitigates radiation-induced lung injury in a large animal model
por: Collie, David, et al.
Publicado: (2018)

Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
por: Schuster, Antje, et al.
Publicado: (2013)

Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
por: Bhagirath, Anjali Y., et al.
Publicado: (2016)

Methylprednisolone: Pseudomonas aeruginosa lung abscess: case report
Publicado: (2022)

N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions
por: Ceylan, Bahadir, et al.
Publicado: (2018)

Pharmacokinetic Characteristics of Nebulized Colistimethate Sodium Using Two Different Types of Nebulizers in Critically Ill Patients with Ventilator-Associated Respiratory Infections
por: Kyriakoudi, Anna, et al.
Publicado: (2022)

Pseudomonas aeruginosa Consumption of Airway Metabolites Promotes Lung Infection
por: Riquelme, Sebastián A., et al.
Publicado: (2021)

ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study
por: Hua, Xueliang, et al.
Publicado: (2020)

Correction: ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study
por: Hua, Xueliang, et al.
Publicado: (2020)

Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
por: Pukhalsky, A L, et al.
Publicado: (1999)

Pseudomonas aeruginosa vesicles associate with and are internalized by human lung epithelial cells
por: Bauman, Susanne J, et al.
Publicado: (2009)

Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa
por: Pewzner-Jung, Yael, et al.
Publicado: (2014)

Recurrent Pseudomonas aeruginosa Infection in Chronic Lung Diseases: Relapse or Reinfection?
por: Yum, Ho-Kee, et al.
Publicado: (2014)

Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
por: Hilliam, Yasmin, et al.
Publicado: (2017)

Synthesized Heparan Sulfate Competitors Attenuate Pseudomonas aeruginosa Lung Infection
por: Lorè, Nicola Ivan, et al.
Publicado: (2018)

Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host?
por: Faure, Emmanuel, et al.
Publicado: (2018)

Genomics of Diversification of Pseudomonas aeruginosa in Cystic Fibrosis Lung-like Conditions
por: Schick, Alana, et al.
Publicado: (2022)

Long-term evolution of antibiotic tolerance in Pseudomonas aeruginosa lung infections
por: Ghoul, Melanie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r1nqu1fhbmifm5k57mi7cmi42c